- Home
- JELD vs ACHV Comparison
JELD vs ACHV Comparison
Compare JELD & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JELD | ACHV |
|---|---|---|
| Founded | 1960 | N/A |
| Country | | |
| Employees | N/A | N/A |
| Industry | Forest Products | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.4M | 231.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JELD | ACHV |
|---|---|---|
| Price | $2.47 | $4.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $3.94 | ★ $15.50 |
| AVG Volume (30 Days) | ★ 1.4M | 713.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.37 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.70 | $1.84 |
| 52 Week High | $8.38 | $6.03 |
Technical Indicators
Market Signals| Indicator | JELD | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 40.42 |
| Support Level | $2.00 | $4.11 |
| Resistance Level | $3.10 | $4.30 |
| Average True Range (ATR) | 0.27 | 0.25 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 43.84 | 49.14 |
Price Performance
Historical ComparisonAbout JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.